Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients

Giuseppe Cianciolo1, Irene Capelli1, Maria Cappuccilli1

  • 1Nephrology, Dialysis and Renal Transplant Unit, S. Orsola Hospital, Department of Experimental Diagnostic and Specialty Medicine (DIMES) , University of Bologna , Bologna , Italy.

Insights

Circulating calcifying cells (CCCs) contribute to vascular calcification, a complication linked to chronic kidney disease-mineral and bone disorders (CKD-MBD). Research is exploring CCC origins and the role of CKD-MBD in their formation and vascular disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Endocrinology

Background:

  • Vascular calcification is a significant risk factor for cardiovascular morbidity and mortality, particularly in patients with chronic kidney disease-mineral and bone disorders (CKD-MBD).
  • Vascular calcification involves an osteogenic cellular program, with circulating calcifying cells (CCCs), derived from bone marrow (BM), implicated in intima calcification.
  • The role of CCCs in conditions like diabetes and atherosclerosis, and their precise origin (BM, bloodstream, or both), remain largely unexplored.

Purpose of the Study:

  • To investigate the role of circulating calcifying cells (CCCs) in vascular calcification, especially in the context of chronic kidney disease-mineral and bone disorders (CKD-MBD).
  • To explore the potential link between CKD-MBD and the formation and function of CCCs.
  • To understand the factors influencing CCC formation and their contribution to the bone-vascular axis.

Main Methods:

  • Analysis of existing studies on circulating calcifying cells (CCCs) and their association with vascular calcification.
  • Review of preliminary data concerning CKD patients and the impact of mineral bone disease on vascular calcification.
  • Exploration of the potential role of parathyroid hormone and osteoblasts in regulating hematopoietic stem/progenitor cells and CCC formation.

Main Results:

  • Studies in non-CKD patients have not found associations between CCCs and bone metabolism markers.
  • Preliminary findings in CKD patients suggest that disruptions in bone marrow (BM) niches due to CKD-MBD may contribute to vascular calcification.
  • CKD-MBD is hypothesized to promote CCC formation due to its effects on hematopoietic stem/progenitor cells.

Conclusions:

  • Circulating calcifying cells (CCCs) are implicated in vascular calcification, a process linked to CKD-MBD.
  • CKD-MBD may promote vascular calcification by disrupting bone marrow (BM) integrity and potentially increasing CCC formation.
  • Further research is needed to elucidate the exact mechanisms of CCC formation and their role in the bone-vascular axis, particularly in the context of CKD, diabetes, and atherosclerosis.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
909
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
581
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.5K